Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hung Lin

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2026
Elevated phthalate exposure and metabolic susceptibility increased breast cancer risk: A 20-y follow-up study in TaiwanHui-Chi Chen, San-Lin You, Ching-Hung Lin, et al.
Plos One|April 25, 2015
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian CountryChing-Hung Lin, Chen-Yang Shen, Jih-Hsiang Lee, et al.
Oncotarget|January 30, 2016
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancerPo-Han Lin, Wen-Hung Kuo, Ai-Chu Huang, et al.
JAMA Oncology|December 21, 2023
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical TrialTom Wei-Wu Chen, Ming-Shen Dai, Ling-Ming Tseng, et al.
Breast Cancer Research and Treatment|February 3, 2022
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patientsPo-Han Lin, Shin-Cheh Chen, Ling-Ming Tseng, et al.
BMC Medicine|March 17, 2022
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysisRyan Shea Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2024
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort StudyRyan Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 28, 2021
The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer CentresLaureline Gatellier, Abhishek Shankar, Luh K Mela Dewi, et al.
Molecular Cancer|June 4, 2026
Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancerYa-Hsuan Chang, Yi-Ju Chen, Zhi-Jie Hong, et al.
Journal of Breast Cancer|July 6, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer ManagementJiun-I Lai, Chih-Chiang Hung, Chin-Yao Lin, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2026
Elevated phthalate exposure and metabolic susceptibility increased breast cancer risk: A 20-y follow-up study in TaiwanHui-Chi Chen, San-Lin You, Ching-Hung Lin, et al.
Plos One|April 25, 2015
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian CountryChing-Hung Lin, Chen-Yang Shen, Jih-Hsiang Lee, et al.
Oncotarget|January 30, 2016
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancerPo-Han Lin, Wen-Hung Kuo, Ai-Chu Huang, et al.
JAMA Oncology|December 21, 2023
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical TrialTom Wei-Wu Chen, Ming-Shen Dai, Ling-Ming Tseng, et al.
Breast Cancer Research and Treatment|February 3, 2022
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patientsPo-Han Lin, Shin-Cheh Chen, Ling-Ming Tseng, et al.
BMC Medicine|March 17, 2022
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysisRyan Shea Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2024
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort StudyRyan Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 28, 2021
The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer CentresLaureline Gatellier, Abhishek Shankar, Luh K Mela Dewi, et al.
Molecular Cancer|June 4, 2026
Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancerYa-Hsuan Chang, Yi-Ju Chen, Zhi-Jie Hong, et al.
Journal of Breast Cancer|July 6, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer ManagementJiun-I Lai, Chih-Chiang Hung, Chin-Yao Lin, et al.
Pageof 14